Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India
New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.
Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc
Mumbai/IBNS: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) Friday declared a year-on-year (YoY) rise in consolidated net profit at Rs 992 crore, up 30 per cent.
Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market
Mumbai/UNI Pharma Major Dr Reddy's Laboratories on Friday announced the US launch of Trientine Hydrochloride Capsules a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the US Food and Drug Administration (USFDA).